PsychoGenics Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:PsychoGenics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013226
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PsychoGenics Inc (PsychoGenics) is an preclinical contract research organization that offers contract research, standard and customized preclinical services and drug discovery services. The organization offers various behavioral tests to drug candidates in the areas of pain and inflammation, psychiatric and neurodegenerative disorders, and spinal cord and traumatic brain injury. Its phenocube is used to identify compounds with potential to treat cognitive impairment. PsychoGenics offers behavioral testing, electrophysiology, microdialysis, and other services. The organization caters to biotechnology, pharmaceutical, and other sectors. PsychoGenics is headquartered in Tarrytown, New York, the US.

PsychoGenics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PsychoGenics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Resilience Therapeutics Enters into Drug Discovery Agreement with PGI 10
PGI Drug Discovery And Roche Expand Drug Discovery Agreement 11
PsychoGenics Extends Drug Discovery Agreement with Sunovion Pharma 12
Afraxis And PsychoGenics Enter Into Partnership To Offer Afraxis’ ESP Technology For Drug Discovery 13
PsychoGenics Enters Into Joint Venture Agreement With KineMed 14
Licensing Agreements 15
PsychoGenics Enters into Licensing Agreement with University of California, San Diego 15
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine for Transgenic Mouse Model of a-Synucleinopathies 16
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine 17
PsychoGenics Enters into Licensing Agreement with McGill University for McGill-R-Thy I-APP 18
PsychoGenics Enters into Licensing Agreement with Yeda Research and Development 19
PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 20
Amarantus Enters Into Licensing Agreement With PGI Drug Discovery For Eltoprazine 21
PsychoGenics Enters Into Licensing Agreement With University of South Florida For APP/PS1 Transgenic Mouse Model 22
PsychoGenics Inc – Key Competitors 23
PsychoGenics Inc – Key Employees 24
PsychoGenics Inc – Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Other Significant Developments 26
Jan 19, 2016: PsychoGenics Expands its Drug Discovery Service Capabilities 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
PsychoGenics Inc, Pharmaceuticals & Healthcare, Key Facts 2
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PsychoGenics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PsychoGenics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Resilience Therapeutics Enters into Drug Discovery Agreement with PGI 10
PGI Drug Discovery And Roche Expand Drug Discovery Agreement 11
PsychoGenics Extends Drug Discovery Agreement with Sunovion Pharma 12
Afraxis And PsychoGenics Enter Into Partnership To Offer Afraxis' ESP Technology For Drug Discovery 13
PsychoGenics Enters Into Joint Venture Agreement With KineMed 14
PsychoGenics Enters into Licensing Agreement with University of California, San Diego 15
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine for Transgenic Mouse Model of a-Synucleinopathies 16
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine 17
PsychoGenics Enters into Licensing Agreement with McGill University for McGill-R-Thy I-APP 18
PsychoGenics Enters into Licensing Agreement with Yeda Research and Development 19
PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 20
Amarantus Enters Into Licensing Agreement With PGI Drug Discovery For Eltoprazine 21
PsychoGenics Enters Into Licensing Agreement With University of South Florida For APP/PS1 Transgenic Mouse Model 22
PsychoGenics Inc, Key Competitors 23
PsychoGenics Inc, Key Employees 24

★海外企業調査レポート[PsychoGenics Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Max Life insurance Co. Ltd.:企業の戦略・SWOT・財務情報
    Max Life insurance Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Max Life insurance Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Clark Enterprises Inc:企業の戦略・SWOT・財務分析
    Clark Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Clark Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Oriental Food Industries Holdings Berhad:企業の戦略・SWOT・財務分析
    Oriental Food Industries Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary Oriental Food Industries Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Highmark Inc:企業の戦略的SWOT分析
    Highmark Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Frisch’s Restaurants, Inc.:戦略・SWOT・企業財務分析
    Frisch's Restaurants, Inc. - Strategy, SWOT and Corporate Finance Report Summary Frisch's Restaurants, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Bioxyne Ltd (BXN):企業の財務・戦略的SWOT分析
    Bioxyne Ltd (BXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Alembic Pharmaceuticals Ltd (APLLTD):製薬・医療:M&Aディール及び事業提携情報
    Summary Alembic Pharmaceuticals Ltd (APL) is a pharmaceutical company which manufactures and markets generic pharmaceutical products. The company’s active pharmaceutical ingredients include macrolides, NSAIDs, and other drugs. It also offers branded formulations in the areas of antibiotics and antib …
  • Banca IFIS SpA:企業の戦略・SWOT・財務情報
    Banca IFIS SpA - Strategy, SWOT and Corporate Finance Report Summary Banca IFIS SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • PerkinElmer Inc (PKI):企業の製品パイプライン分析
    Summary PerkinElmer Inc (PerkinElmer) is a provider of detection and imaging technologies, consumables, informatics solutions, accessories and services. The company’s major products include cytogenetics reagents, ELISA Kits, tissue biomarker reagents, atomic spectroscopy instruments, chromatography …
  • Mytilineos Holdings Sa
    Mytilineos Holdings Sa - Strategy, SWOT and Corporate Finance Report Summary Mytilineos Holdings Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Unilab (Philippines) Inc:企業の戦略的SWOT分析
    Unilab (Philippines) Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Ginkgo BioWorks Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Ginkgo BioWorks Inc (Ginkgo BioWorks) is a biotechnology company which offers automated organism engineering, enzyme discovery and cultured fragrances. The company build's foundries to scale the process of organism engineering using software and hardware automation tools. It produces ingredi …
  • Gabather AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Gabather AB (Gabather) is a developer of new drug candidates for the treatment of central nervous system diseases. The company spans its expertise in the development of anti-psychotics, anti-depressants and anxiolytics, analgesics, and cognition-enhancing treatments. It offers drug candidate …
  • Oltchim SA (OLT):企業の財務・戦略的SWOT分析
    Summary Oltchim SA (Oltchim) is a chemical company that manufactures and markets petrochemical products. The company offers inorganic, macro molecular and organic synthesis products. Its inorganic products include caustic soda, liquid chlorine, hydrochloric acid and sodium hypochlorite. Oltchim's ma …
  • Largan Precision Co Ltd (3008):企業の財務・戦略的SWOT分析
    Largan Precision Co Ltd (3008) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Valero Energy Corp (VLO):企業の財務・戦略的SWOT分析
    Valero Energy Corp (VLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Flint Hills Resources LLC:企業の戦略的SWOT分析
    Flint Hills Resources LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Airbus SAS:戦略・SWOT・企業財務分析
    Airbus SAS - Strategy, SWOT and Corporate Finance Report Summary Airbus SAS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Hogg Robinson Group Limited:企業の戦略・SWOT・財務分析
    Hogg Robinson Group Limited - Strategy, SWOT and Corporate Finance Report Summary Hogg Robinson Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • XBiotech Inc (XBIT):製薬・医療:M&Aディール及び事業提携情報
    Summary XBiotech Inc (XBiotech) is a biopharmaceutical company that discovers, develops and commercialize therapeutic antibodies based proprietary technology. The company provides monoclonal antibodies treatment for various diseases. It’s lead product Xilonix, a therapeutic antibody being developed …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆